Se	O
examinaron	O
los	O
mecanismos	O
de	O
mediación	O
de	O
una	O
intervención	O
de	O
ejercicio	O
grupal	O
de	O
12	O
semanas	O
sobre	O
la	O
calidad	O
de	O
vida	O
(	O
QoL	O
)	O
de	O
los	O
sobrevivientes	O
de	O
cáncer	O
para	O
informar	O
el	O
desarrollo	O
futuro	O
de	O
la	O
intervención	O
de	O
ejercicio	O
.	O

Doscientos	O
nueve	O
sobrevivientes	O
de	O
cáncer	O
≥	O
3	O
meses	O
después	O
del	O
tratamiento	O
(	O
57	O
%	O
cáncer	O
de	O
mama	O
)	O
de	O
49,5	O
(	O
±	O
10,4	O
)	O
años	O
fueron	O
asignados	O
a	O
ejercicio	O
físico	O
(	O
n	O
=	O
147	O
)	O
o	O
control	O
en	O
lista	O
de	O
espera	O
(	O
n	O
=	O
62	O
)	O
.	O

Se	O
evaluaron	O
la	O
CdV	O
,	O
la	O
fatiga	O
,	O
la	O
angustia	O
emocional	O
,	O
la	O
actividad	O
física	O
,	O
la	O
autoeficacia	O
general	O
y	O
el	O
dominio	O
al	O
inicio	O
y	O
después	O
de	O
la	O
intervención	O

usando	O
cuestionarios	O

.	O

Se	O
realizó	O
un	O
análisis	O
de	O
ruta	O
utilizando	O
Mplus	O
para	O
explorar	O
si	O
la	O
actividad	O
física	O
mejorada	O
,	O
la	O
autoeficacia	O
general	O
y	O
el	O
dominio	O
mediaban	O
los	O
efectos	O
del	O
ejercicio	O
sobre	O
la	O
fatiga	O
y	O
la	O
angustia	O
y	O
,	O
en	O
consecuencia	O
,	O
la	O
CdV	O
.	O

La	B-Premise-Support-5
intervención	I-Premise-Support-5
se	I-Premise-Support-5
asoció	I-Premise-Support-5
con	I-Premise-Support-5
un	I-Premise-Support-5
aumento	I-Premise-Support-5
de	I-Premise-Support-5
la	I-Premise-Support-5
actividad	I-Premise-Support-5
física	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
0,46	I-Premise-Support-5
,	I-Premise-Support-5
intervalo	I-Premise-Support-5
de	I-Premise-Support-5
confianza	I-Premise-Support-5
(	I-Premise-Support-5
IC	I-Premise-Support-5
)	I-Premise-Support-5
del	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
0,14	I-Premise-Support-5
;	I-Premise-Support-5
0,59	I-Premise-Support-5
)	I-Premise-Support-5
,	I-Premise-Support-5
autoeficacia	I-Premise-Support-5
general	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
2,41	I-Premise-Support-5
,	I-Premise-Support-5
IC	I-Premise-Support-5
del	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
0,35	I-Premise-Support-5
;	I-Premise-Support-5
4,73	I-Premise-Support-5
)	I-Premise-Support-5
y	I-Premise-Support-5
dominio	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
1,75	I-Premise-Support-5
,	I-Premise-Support-5
IC95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
0,36	I-Premise-Support-5
;	I-Premise-Support-5
2,78	I-Premise-Support-5
)	I-Premise-Support-5
.	I-Premise-Support-5
Además	O
,	O
la	B-Premise-Support-5
intervención	I-Premise-Support-5
tuvo	I-Premise-Support-5
un	I-Premise-Support-5
efecto	I-Premise-Support-5
directo	I-Premise-Support-5
sobre	I-Premise-Support-5
la	I-Premise-Support-5
fatiga	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
-1,09	I-Premise-Support-5
,	I-Premise-Support-5
IC	I-Premise-Support-5
del	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
-2,12	I-Premise-Support-5
;	I-Premise-Support-5
0,01	I-Premise-Support-5
)	I-Premise-Support-5
y	I-Premise-Support-5
un	I-Premise-Support-5
efecto	I-Premise-Support-5
indirecto	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
-0,54	I-Premise-Support-5
,	I-Premise-Support-5
IC	I-Premise-Support-5
del	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
-1,00	I-Premise-Support-5
;	I-Premise-Support-5
-0,21	I-Premise-Support-5
)	I-Premise-Support-5
a	I-Premise-Support-5
través	I-Premise-Support-5
de	I-Premise-Support-5
la	I-Premise-Support-5
actividad	I-Premise-Support-5
física	I-Premise-Support-5
.	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
-0,29	I-Premise-Support-5
,	I-Premise-Support-5
IC	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
-0,64	I-Premise-Support-5
;	I-Premise-Support-5
-0,07	I-Premise-Support-5
)	I-Premise-Support-5
y	I-Premise-Support-5
autoeficacia	I-Premise-Support-5
general	I-Premise-Support-5
(	I-Premise-Support-5
β	I-Premise-Support-5
=	I-Premise-Support-5
-0,25	I-Premise-Support-5
,	I-Premise-Support-5
IC	I-Premise-Support-5
95	I-Premise-Support-5
%	I-Premise-Support-5
=	I-Premise-Support-5
-0,61	I-Premise-Support-5
;	I-Premise-Support-5
-0,05	I-Premise-Support-5
)	I-Premise-Support-5
.	I-Premise-Support-5

La	B-Premise-Support-3
intervención	I-Premise-Support-3
tuvo	I-Premise-Support-3
un	I-Premise-Support-3
efecto	I-Premise-Support-3
directo	I-Premise-Support-3
significativo	I-Premise-Support-3
limítrofe	I-Premise-Support-3
sobre	I-Premise-Support-3
la	I-Premise-Support-3
reducción	I-Premise-Support-3
de	I-Premise-Support-3
la	I-Premise-Support-3
angustia	I-Premise-Support-3
(	I-Premise-Support-3
β	I-Premise-Support-3
=	I-Premise-Support-3
-1,32	I-Premise-Support-3
,	I-Premise-Support-3
IC	I-Premise-Support-3
del	I-Premise-Support-3
95	I-Premise-Support-3
%	I-Premise-Support-3
=	I-Premise-Support-3
-2,68	I-Premise-Support-3
;	I-Premise-Support-3
0,11	I-Premise-Support-3
)	I-Premise-Support-3
,	I-Premise-Support-3
y	I-Premise-Support-3
un	I-Premise-Support-3
efecto	I-Premise-Support-3
indirecto	I-Premise-Support-3
significativo	I-Premise-Support-3
a	I-Premise-Support-3
través	I-Premise-Support-3
del	I-Premise-Support-3
aumento	I-Premise-Support-3
de	I-Premise-Support-3
la	I-Premise-Support-3
autoeficacia	I-Premise-Support-3
general	I-Premise-Support-3
y	I-Premise-Support-3
el	I-Premise-Support-3
dominio	I-Premise-Support-3
(	I-Premise-Support-3
β	I-Premise-Support-3
=	I-Premise-Support-3
-1,06	I-Premise-Support-3
,	I-Premise-Support-3
IC	I-Premise-Support-3
del	I-Premise-Support-3
95	I-Premise-Support-3
%	I-Premise-Support-3
=	I-Premise-Support-3
-1,89	I-Premise-Support-3
;	I-Premise-Support-3
-0,38	I-Premise-Support-3
)	I-Premise-Support-3
.	I-Premise-Support-3

Las	O
reducciones	B-Premise-Support-2
en	I-Premise-Support-2
la	I-Premise-Support-2
fatiga	I-Premise-Support-2
(	I-Premise-Support-2
β	I-Premise-Support-2
=	I-Premise-Support-2
-1,33	I-Premise-Support-2
,	I-Premise-Support-2
IC	I-Premise-Support-2
del	I-Premise-Support-2
95	I-Premise-Support-2
%	I-Premise-Support-2
=	I-Premise-Support-2
-1,85	I-Premise-Support-2
;	I-Premise-Support-2
-0,83	I-Premise-Support-2
)	I-Premise-Support-2
y	I-Premise-Support-2
la	I-Premise-Support-2
angustia	I-Premise-Support-2
(	I-Premise-Support-2
β	I-Premise-Support-2
=	I-Premise-Support-2
-0,86	I-Premise-Support-2
,	I-Premise-Support-2
IC	I-Premise-Support-2
del	I-Premise-Support-2
95	I-Premise-Support-2
%	I-Premise-Support-2
=	I-Premise-Support-2
-1,25	I-Premise-Support-2
;	I-Premise-Support-2
-0,52	I-Premise-Support-2
)	I-Premise-Support-2
se	I-Premise-Support-2
asociaron	I-Premise-Support-2
con	I-Premise-Support-2
una	I-Premise-Support-2
mejor	I-Premise-Support-2
CdV	I-Premise-Support-2
.	I-Premise-Support-2

Además	O
,	O
el	O
aumento	B-Premise-Support-1
de	I-Premise-Support-1
la	I-Premise-Support-1
actividad	I-Premise-Support-1
física	I-Premise-Support-1
se	I-Premise-Support-1
asoció	I-Premise-Support-1
directamente	I-Premise-Support-1
con	I-Premise-Support-1
una	I-Premise-Support-1
mejor	I-Premise-Support-1
CdV	I-Premise-Support-1
(	I-Premise-Support-1
β	I-Premise-Support-1
=	I-Premise-Support-1
3,37	I-Premise-Support-1
,	I-Premise-Support-1
IC	I-Premise-Support-1
del	I-Premise-Support-1
95	I-Premise-Support-1
%	I-Premise-Support-1
=	I-Premise-Support-1
1,01	I-Premise-Support-1
;	I-Premise-Support-1
5,54	I-Premise-Support-1
)	I-Premise-Support-1
.	I-Premise-Support-1

El	B-Claim
efecto	I-Claim
beneficioso	I-Claim
del	I-Claim
ejercicio	I-Claim
físico	I-Claim
en	I-Claim
grupo	I-Claim
sobre	I-Claim
la	I-Claim
calidad	I-Claim
de	I-Claim
vida	I-Claim
estuvo	I-Claim
mediado	I-Claim
por	I-Claim
el	I-Claim
aumento	I-Claim
de	I-Claim
la	I-Claim
actividad	I-Claim
física	I-Claim
,	I-Claim
la	I-Claim
autoeficacia	I-Claim
general	I-Claim
y	I-Claim
el	I-Claim
dominio	I-Claim
,	I-Claim
y	I-Claim
las	I-Claim
reducciones	I-Claim
posteriores	I-Claim
de	I-Claim
la	I-Claim
fatiga	I-Claim
y	I-Claim
la	I-Claim
angustia	I-Claim
.	I-Claim

Además	B-Claim
de	I-Claim
la	I-Claim
actividad	I-Claim
física	I-Claim
,	I-Claim
las	I-Claim
futuras	I-Claim
intervenciones	I-Claim
deben	I-Claim
centrarse	I-Claim
en	I-Claim
la	I-Claim
autoeficacia	I-Claim
y	I-Claim
el	I-Claim
dominio	I-Claim
.	I-Claim

Esto	B-Claim-Support--1
puede	I-Claim-Support--1
conducir	I-Claim-Support--1
a	I-Claim-Support--1
una	I-Claim-Support--1
reducción	I-Claim-Support--1
de	I-Claim-Support--1
la	I-Claim-Support--1
angustia	I-Claim-Support--1
y	I-Claim-Support--1
la	I-Claim-Support--1
fatiga	I-Claim-Support--1
y	I-Claim-Support--1
,	I-Claim-Support--1
en	I-Claim-Support--1
consecuencia	I-Claim-Support--1
,	I-Claim-Support--1
a	I-Claim-Support--1
una	I-Claim-Support--1
mejor	I-Claim-Support--1
calidad	I-Claim-Support--1
de	I-Claim-Support--1
vida	I-Claim-Support--1
de	I-Claim-Support--1
los	I-Claim-Support--1
sobrevivientes	I-Claim-Support--1
de	I-Claim-Support--1
cáncer	I-Claim-Support--1
.	I-Claim-Support--1

